|
STAR Introduction
STAR Background
STAR-At-A Glance
STAR Enrollment Statistics
STAR Images
STAR Participant Advisory Board
(PAB)
STAR Publications
STAR Result Images
STAR Q and A
|
The following links will take you to press releases and other materials
concerning the STAR trial that have been prepared by the National Cancer Institute's
Office of Communications.
Initial Results of the Study of Tamoxifen and Raloxifene (STAR) Released: Osteoporosis
Drug Raloxifene Shown to be as Effective as Tamoxifen in Preventing Invasive Breast
Cancer
(Posted: 04/17/2006) - Initial results of the Study of Tamoxifen and Raloxifene,
or STAR, show that the drug raloxifene, currently used to prevent and treat osteoporosis
in postmenopausal women, works as well as tamoxifen in reducing breast cancer risk
for postmenopausal women at increased risk of the disease. Questions
and Answers
Major Breast Cancer Prevention Study Enters Final Stretch
An article from the March 9, 2004, issue of the NCI Cancer Bulletin.
|
